UBS Group’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,297
Closed -$2.07K 10125
2022
Q4
$2.07K Buy
+2,297
New +$2.07K ﹤0.01% 8541
2022
Q2
Sell
-2,571
Closed -$6K 10510
2022
Q1
$6K Buy
2,571
+351
+16% +$819 ﹤0.01% 8019
2021
Q4
$7K Buy
2,220
+1,049
+90% +$3.31K ﹤0.01% 8107
2021
Q3
$4K Sell
1,171
-2,190
-65% -$7.48K ﹤0.01% 7624
2021
Q2
$16K Buy
3,361
+1,258
+60% +$5.99K ﹤0.01% 6526
2021
Q1
$11K Buy
2,103
+450
+27% +$2.35K ﹤0.01% 6874
2020
Q4
$11K Sell
1,653
-477
-22% -$3.17K ﹤0.01% 6439
2020
Q3
$22K Buy
2,130
+1,044
+96% +$10.8K ﹤0.01% 5398
2020
Q2
$14K Buy
1,086
+192
+21% +$2.48K ﹤0.01% 5962
2020
Q1
$10K Buy
894
+60
+7% +$671 ﹤0.01% 6053
2019
Q4
$4K Buy
+834
New +$4K ﹤0.01% 6639
2019
Q3
Sell
-733
Closed -$7K 7341
2019
Q2
$7K Sell
733
-553
-43% -$5.28K ﹤0.01% 6409
2019
Q1
$13K Buy
1,286
+19
+1% +$192 ﹤0.01% 5830
2018
Q4
$15K Buy
1,267
+189
+18% +$2.24K ﹤0.01% 6087
2018
Q3
$17K Buy
1,078
+972
+917% +$15.3K ﹤0.01% 5985
2018
Q2
$4K Sell
106
-305
-74% -$11.5K ﹤0.01% 6664
2018
Q1
$13K Buy
+411
New +$13K ﹤0.01% 5855
2017
Q3
Sell
-671
Closed -$13K 7016
2017
Q2
$13K Buy
+671
New +$13K ﹤0.01% 5674
2016
Q4
Sell
-618
Closed -$13K 7019
2016
Q3
$13K Buy
618
+567
+1,112% +$11.9K ﹤0.01% 5714
2016
Q2
$1K Sell
51
-29
-36% -$569 ﹤0.01% 6672
2016
Q1
$3K Buy
80
+18
+29% +$675 ﹤0.01% 6367
2015
Q4
$3K Sell
62
-363
-85% -$17.6K ﹤0.01% 6512
2015
Q3
$33K Buy
425
+382
+888% +$29.7K ﹤0.01% 5042
2015
Q2
$5K Sell
43
-54
-56% -$6.28K ﹤0.01% 6309
2015
Q1
$13K Buy
+97
New +$13K ﹤0.01% 5723